BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 17007555)

  • 21. The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability in human somatic cells.
    Stolz A; Ertych N; Kienitz A; Vogel C; Schneider V; Fritz B; Jacob R; Dittmar G; Weichert W; Petersen I; Bastians H
    Nat Cell Biol; 2010 May; 12(5):492-9. PubMed ID: 20364141
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification and functional characterization of a PP1-binding site in BRCA1.
    Hsu LC
    Biochem Biophys Res Commun; 2007 Aug; 360(2):507-12. PubMed ID: 17603999
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of ATM/DNA-PKcs Phosphorylation by BRCA1-Associated BAAT1.
    Ouchi M; Ouchi T
    Genes Cancer; 2010 Dec; 1(12):1211-4. PubMed ID: 21779444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polo-like kinase 4 phosphorylates Chk2.
    Petrinac S; Ganuelas ML; Bonni S; Nantais J; Hudson JW
    Cell Cycle; 2009 Jan; 8(2):327-9. PubMed ID: 19164942
    [No Abstract]   [Full Text] [Related]  

  • 25. The impact of tissue microenvironment on treatment simulation.
    Daşu A; Denekamp J
    Adv Exp Med Biol; 2003; 510():63-7. PubMed ID: 12580406
    [No Abstract]   [Full Text] [Related]  

  • 26. The relevance and measurement of tumor hypoxia. Proceedings of a consensus meeting. Leuven, Belgium, December 7 and 8, 1989.
    Radiother Oncol; 1991; 20 Suppl 1():1-157. PubMed ID: 2020759
    [No Abstract]   [Full Text] [Related]  

  • 27. Multifaceted control of DNA repair pathways by the hypoxic tumor microenvironment.
    Scanlon SE; Glazer PM
    DNA Repair (Amst); 2015 Aug; 32():180-189. PubMed ID: 25956861
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hypoxic stress facilitates acute activation and chronic downregulation of fanconi anemia proteins.
    Scanlon SE; Glazer PM
    Mol Cancer Res; 2014 Jul; 12(7):1016-28. PubMed ID: 24688021
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hypoxia and DNA repair.
    Glazer PM; Hegan DC; Lu Y; Czochor J; Scanlon SE
    Yale J Biol Med; 2013 Dec; 86(4):443-51. PubMed ID: 24348208
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Tumor hypoxia as a driving force in genetic instability.
    Luoto KR; Kumareswaran R; Bristow RG
    Genome Integr; 2013 Oct; 4(1):5. PubMed ID: 24152759
    [TBL] [Abstract][Full Text] [Related]  

  • 31. X-ray structures of checkpoint kinase 2 in complex with inhibitors that target its gatekeeper-dependent hydrophobic pocket.
    Lountos GT; Jobson AG; Tropea JE; Self CR; Zhang G; Pommier Y; Shoemaker RH; Waugh DS
    FEBS Lett; 2011 Oct; 585(20):3245-9. PubMed ID: 21907711
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Targeting hypoxia in cancer therapy.
    Wilson WR; Hay MP
    Nat Rev Cancer; 2011 Jun; 11(6):393-410. PubMed ID: 21606941
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas.
    Squatrito M; Brennan CW; Helmy K; Huse JT; Petrini JH; Holland EC
    Cancer Cell; 2010 Dec; 18(6):619-29. PubMed ID: 21156285
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Targeting hypoxic cells through the DNA damage response.
    Olcina M; Lecane PS; Hammond EM
    Clin Cancer Res; 2010 Dec; 16(23):5624-9. PubMed ID: 20876254
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Src-Induced cisplatin resistance mediated by cell-to-cell communication.
    Peterson-Roth E; Brdlik CM; Glazer PM
    Cancer Res; 2009 Apr; 69(8):3619-24. PubMed ID: 19351863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CHK2-dependent phosphorylation of BRCA1 in hypoxia.
    Gibson SL; Bindra RS; Glazer PM
    Radiat Res; 2006 Oct; 166(4):646-51. PubMed ID: 17007555
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ataxia telangiectasia mutated and checkpoint kinase 2 regulate BRCA1 to promote the fidelity of DNA end-joining.
    Wang HC; Chou WC; Shieh SY; Shen CY
    Cancer Res; 2006 Feb; 66(3):1391-400. PubMed ID: 16452194
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypoxia-induced phosphorylation of Chk2 in an ataxia telangiectasia mutated-dependent manner.
    Gibson SL; Bindra RS; Glazer PM
    Cancer Res; 2005 Dec; 65(23):10734-41. PubMed ID: 16322218
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Priming phosphorylation of Chk2 by polo-like kinase 3 (Plk3) mediates its full activation by ATM and a downstream checkpoint in response to DNA damage.
    Bahassi el M; Myer DL; McKenney RJ; Hennigan RF; Stambrook PJ
    Mutat Res; 2006 Apr; 596(1-2):166-76. PubMed ID: 16481012
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role for ATM in DNA damage-induced phosphorylation of BRCA1.
    Gatei M; Scott SP; Filippovitch I; Soronika N; Lavin MF; Weber B; Khanna KK
    Cancer Res; 2000 Jun; 60(12):3299-304. PubMed ID: 10866324
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.